The agenda for EuroSciCon's ‘From Menace to Marvel: Nitric Oxide in Health and Disease’ meeting on March 20th 2009 has been finalised.
Professor Ian Megson (UHi Millenium Institute,
‘Since its discovery in the 1980s, nitric oxide (NO) has been heralded as a major breakthrough in disease prevention and management. However, the promise and expectations have not yet been delivered with respect to new NO donor drugs on the market and we are still heavily reliant on drugs that have been in use for decades. One possible reason for the lack of development in this area is the lack of specificity of many NO donor drugs and their global impact, as opposed to local activity.’ His talk will explore some possible solutions to tackle targeted NO delivery for use in a number of cardiovascular conditions and will highlight the enormity of the task ahead to fully exploit the remarkable potential of NO in health and disease.
Talks include:
The nitrate-nitrite-NO pathway in health and disease - Dr Jon Lundberg,
Targeting eNOS coupling in human atherosclerosis - Dr. Charalambos Antoniades,
Nitrite: Can we teach an old dog new tricks? - Dr Alexandra Milsom, Barts & The
Nitric oxide in the life and death of neuronal cells –Dr Guy Brown, Department of Biochemistry,
The where, why and how of targeted nitric oxide delivery – Professor Ian Megson, UHi Millenium Institute,
S-Nitrosoglutathione Metabolism - Dr Lea-Ann Dailey, King's College,
Nitric Oxide management strategies in pathogenic enterobacteria - Professor David Richardson
.
Hydrogen sulfide and the nitric oxide cross-talk: A promising future for two old gas bags? - Dr Matt Whitemann,
As well as talks by the Chair, Dr Alan Wallace (AstraZeneca
Book a place now by visiting http://www.regonline.co.uk/no09
